000 01445 a2200385 4500
005 20250515085204.0
264 0 _c20080117
008 200801s 0 0 eng d
022 _a0361-6878
024 7 _a10.1215/03616878-2007-030
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJacobson, Peter D
245 0 0 _aLitigating the science of breast cancer treatment.
_h[electronic resource]
260 _bJournal of health politics, policy and law
_cOct 2007
300 _a785-818 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBone Marrow Transplantation
_xeconomics
650 0 4 _aBreast Neoplasms
_xeconomics
650 0 4 _aCombined Modality Therapy
650 0 4 _aDiffusion of Innovation
650 0 4 _aEvidence-Based Medicine
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInsurance Claim Review
_xlegislation & jurisprudence
650 0 4 _aInsurance Coverage
_xlegislation & jurisprudence
650 0 4 _aNeoplasm Metastasis
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aTreatment Outcome
650 0 4 _aUnited States
700 1 _aRettig, Richard A
700 1 _aAubry, Wade M
773 0 _tJournal of health politics, policy and law
_gvol. 32
_gno. 5
_gp. 785-818
856 4 0 _uhttps://doi.org/10.1215/03616878-2007-030
_zAvailable from publisher's website
999 _c17383018
_d17383018